Blood-stage malaria vaccine candidate RH5.1/Matrix-M in healthy Tanzanian adults and children; an open-label, non-randomised, first-in-human, single-centre, phase 1b trial.
Silk SE. et al, (2024), Lancet Infect Dis, 24, 1105 - 1117
Higher HIV-1 evolutionary rate is associated with cytotoxic T lymphocyte escape mutations in infants.
Nazziwa J. et al, (2024), J Virol
PvDBPII elicits multiple antibody-mediated mechanisms that reduce growth in a Plasmodium vivax challenge trial.
Martinez FJ. et al, (2024), NPJ Vaccines, 9
PvDBPII-Matrix M elicits polyfunctional antibodies that limit parasite growth in a challenge trial
Martinez FJ. et al, (2023)
Vaccination with Plasmodium vivax Duffy-binding protein inhibits parasite growth during controlled human malaria infection.
Hou MM. et al, (2023), Sci Transl Med, 15
Analyses of human vaccine-specific circulating and bone marrow-resident B cell populations reveal benefit of delayed vaccine booster dosing with blood-stage malaria antigens.
Barrett JR. et al, (2023), Front Immunol, 14
Repeat controlled human malaria infection of healthy UK adults with blood-stage Plasmodium falciparum: Safety and parasite growth dynamics.
Salkeld J. et al, (2022), Front Immunol, 13
Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial.
Ramasamy MN. et al, (2021), Lancet, 396, 1979 - 1993
Controlled human malaria infection with a clone of Plasmodium vivax with high-quality genome assembly.
Minassian AM. et al, (2021), JCI Insight, 6
Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 lineages circulating in Brazil
Clemens SAC. et al, (2021), Nature Communications, 12
Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 lineages circulating in Brazil.
Clemens SAC. et al, (2021), Nat Commun, 12
Reactogenicity and immunogenicity after a late second dose or a third dose of ChAdOx1 nCoV-19 in the UK: a substudy of two randomised controlled trials (COV001 and COV002).
Flaxman A. et al, (2021), Lancet, 398, 981 - 990
Fatal tuberculous meningitis in an infant presenting with seizures in the UK.
Khambati N. et al, (2021), BMJ Case Rep, 14
Controlled human malaria infection with PvW1 – a new clone of Plasmodium vivax with high quality genome assembly
Minassian AM. et al, (2021)
Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials.
Voysey M. et al, (2021), Lancet, 397, 881 - 891